Soar BioDynamics Enhances Online Report for Men with Elevated PSA Scores

November 2, 2009

New features and resources launch on Web site

SAN FRANCISCO, Nov. 2 /PRNewswire/ -- Soar BioDynamics, a San Francisco-based, personal health analytics company, announced today the availability of its updated, user-friendly Cancer Probability Report. The report is designed to give men and their doctors a brief but clear understanding of their likelihood of progressing prostate cancer and recommended action steps. In addition, the company's newly enhanced Web site, www.SoarBioDynamics.com, has expanded information about the PSA debate plus new navigational tools and graphic illustrations.

Through its 'Dynamic Screening' process, Soar's proprietary analytics technology helps men with elevated PSA scores and their doctors by providing users with simple access to a rigorous analysis of a patient's test results and medical history. This medical data is compared against tens of thousands of cases that can help the patient and doctor quickly narrow in on a personalized approach to care.

"Soar BioDynamics brings game-changing evidence-based analysis to help men and their doctors cut through the controversy and information overload," said CEO and Chief Scientist Tom Neville, Ph.D. "The Cancer Probability Report is easy to understand and helps bring context to PSA scores, allowing doctors to apply best practices that lead to better outcomes."

Other enhanced resources on the Web site include:

    --  Elevated PSA? Provides patients concerned about abnormal PSA scores with
        a clear guide to the issues surrounding prostate screening tests. On the
        page, visitors can walk through what an elevated PSA score means, the
        problem of overtreatment and how to use Soar BioDynamics Screening with
        doctors.
    --  Why Screen? Gives information about the prevalence of prostate cancer
        and an overview of the controversies surrounding screening tests.
    --  About Soar BioDynamics: Discusses Soar's Dynamic Screening that
        synthesizes best practices validated by the latest peer-reviewed medical
        research for more reliable detection.

    --  Dynamic Screening: Offers additional resources such as a glossary of
        medical terms, frequently asked questions and a page for physicians,
        with data points, research and links to leading medical centers using
        dynamic screening best practices.

How the Dynamic Screening Process Works

Patients enter their medical information on www.SoarBioDynamics.com and receive via email their Cancer Probability Report, a personalized analysis with a cancer probability scenario and recommended action paths. Soar Dynamic Screening uses research-based mathematical analysis to augment existing information by trending patients' individual blood test results and other factors over time and comparing them to those of representative populations. As a result, Soar Dynamic Screening aids in the identification of early indications of prostatitis, BPH and cancer. This analysis may be used to reduce the risk of false positive biopsy results, recurrence of cancer after initial treatment and discovery of indolent cancer when compared to conventional screening. Users can now select to receive their Cancer Probability Report as a short easy-to-read summary or a more detailed analysis.

About Soar BioDynamics, Ltd.

Soar BioDynamics harnesses the power of advanced mathematical computation to bring bold new perspective to common medical test results with an easy-to-use Web-based system. Dynamic Screening for prostate cancer is Soar's first invention that has been expanded to screening for prostatitis and BPH. Soar's Cancer Probability Report can help bring context to PSA test results and help patients and doctors make more enlightened choices about further tests, referrals or treatments.

For more information regarding Soar BioDynamics, Ltd. or to view a sample report, please visit http://www.SoarBioDynamics.com.

SOURCE Soar BioDynamics, Ltd.